Granulocyte colony-stimulating factor-mobilized granulocyte concentrate transfusions

Area of Science:

• Hematology
• Transfusion Medicine
• Oncology Supportive Care

Background:

• Granulocyte transfusion therapy has seen limited use due to perceived low efficacy in treating infected neutropenic patients.
• Inadequate granulocyte yields from standard leukapheresis have historically limited treatment effectiveness.
• Recombinant granulocyte colony-stimulating factor (G-CSF) offers a potential solution to increase granulocyte collection.

Purpose of the Study:

• To evaluate the impact of G-CSF stimulation on granulocyte collection and transfusion efficacy.
• To assess the safety and tolerability of G-CSF in normal donors.
• To determine if enhanced granulocyte yields translate to improved clinical outcomes.

Main Methods:

• Normal donors were stimulated with G-CSF, with or without corticosteroids, prior to leukapheresis.
• Granulocyte yields were measured and compared to standard collection methods.
• Neutrophil counts in recipient patients were monitored post-transfusion.
• In vitro and in vivo functional assays assessed granulocyte quality.

Main Results:

• G-CSF stimulation, with or without corticosteroids, was well-tolerated by donors.
• Granulocyte yields increased three- to four-fold compared to standard techniques.
• Patients receiving transfusions showed substantial increases in blood neutrophil counts, often normalizing and persisting for over 24 hours.
• Collected granulocytes demonstrated normal functional capabilities in vitro and in vivo.

Conclusions:

• G-CSF stimulation significantly enhances granulocyte collection, improving donor safety and yield.
• Increased granulocyte doses lead to significant, sustained increases in patient neutrophil counts.
• While early results are encouraging, the definitive clinical efficacy of this enhanced granulocyte transfusion therapy remains to be established.